Improving Metabolism May Halve Risk of Advanced Intestinal Polyp Recurrence

Improving metabolic health can reduce the risk of advanced colorectal neoplasia recurrence by approximately 50% in patients with a history of intestinal polyps, according to research from National Taiwan University Hospital published in JAMA Network Open. The study identifies a strong link between metabolic dysfunction—specifically insulin resistance and high triglyceride levels—and the regrowth of advanced adenomas after colonoscopy.

The research focused on the relationship between metabolic syndrome and the recurrence of advanced adenomas, which are precancerous polyps with a higher potential to develop into colorectal cancer. Researchers found that patients with metabolic dysfunction faced a significantly higher risk of these polyps returning in an advanced form compared to those with healthy metabolic profiles.

A primary driver of this risk is Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), formerly known as non-alcoholic fatty liver disease. According to the findings, the presence of MASLD and related metabolic markers correlates with a higher incidence of advanced colorectal neoplasia recurrence.

The study highlights two specific biomarkers as critical indicators of risk: insulin resistance and elevated triglycerides. When these metabolic markers are poorly controlled, the environment in the colon becomes more conducive to the growth of advanced adenomas.

Conversely, the data suggests that patients who manage or improve these metabolic factors can halve their risk of advanced recurrence. This indicates that metabolic health is not just a comorbid condition but a modifiable risk factor for the development of colorectal tumors.

National Taiwan University Hospital researchers utilized colonoscopy data to track the recurrence of polyps. They categorized the neoplasms based on their size and histological features to distinguish between simple polyps and advanced adenomas.

The analysis suggests that the systemic inflammation and hormonal imbalances associated with insulin resistance may promote the proliferation of cells in the intestinal lining, accelerating the transition from a benign polyp to an advanced neoplasm.

The findings emphasize the importance of a multidisciplinary approach to colorectal cancer prevention. While colonoscopies are essential for the physical removal of polyps, the study argues that managing the underlying metabolic environment is necessary to prevent the return of high-risk growths.

The research underscores that metabolic health interventions—targeting triglyceride reduction and the improvement of insulin sensitivity—serve as a secondary layer of prevention alongside standard endoscopic surveillance.

Because MASLD is increasingly common due to rising rates of obesity and type 2 diabetes, the researchers suggest that screening for metabolic dysfunction should be a consideration for patients undergoing regular colorectal surveillance.